SPECTRAL AI, INC. Proceeds from Sale and Maturity of Marketable Securities
SPECTRAL AI, INC. (MDAI) reported Proceeds from Sale and Maturity of Marketable Securities of $1.03 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2023-03-31
- SPECTRAL AI, INC. proceeds from sale and maturity of marketable securities for fiscal 2022 was $1.03M.
- SPECTRAL AI, INC. proceeds from sale and maturity of marketable securities for fiscal 2021 was $0.00.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|
| 2022-12-31 | $1.03M 10-K · filed 2023-03-31 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |